Is a complete ELAB research report available?

No complete published report is available for PMGC Holdings Inc. (ELAB) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

PMGC Holdings Inc. (ELAB)

NASDAQ: ELAB · USD

$2.56

-0.02 (-0.8%)· Recorded snapshot

Market cap	2.1M
Revenue (ttm)	2.6M
Net income (ttm)	-13.5M
EPS (ttm)	-$99.8
Shares out	809.6K
Volume	6,639
Beta	-0.27

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 2.6M
Net income (ttm): -13.5M
EPS (ttm): -$99.8
Market cap: 2.1M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Держать

Metric	Value
Amount currency	USD
CIK code	0001840563
Company name	PMGC Holdings Inc.
Country	United States
Country code	US
CUSIP number	73017P607
Earnings date	2026-11-10
Earnings time	bmo
Employees	34
Employees change	31
Employees growth	1,033.33%
Enterprise value	$-2.7M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2020
Industry	Biotechnology
IPO date	2023-11-21
Is primary listing	Yes
Is SPAC	No
ISIN number	US73017P6079
Last 10-K release date	2026-03-30
Last earnings date	2026-08-14
Last refreshed	2026-10-28
Last stock split date	2026-08-21
Last stock split type	Reverse
Market cap	$2.1M
Market cap category	Nano-Cap
Next earnings date	2026-11-10
Options	No
Price	$2.56
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	ELAB
U.S. state	California
Website	https://pmgcholdings.com

Metric

Value

Amount currency

USD

CIK code

0001840563

Company name

PMGC Holdings Inc.

Country

United States

Country code

CUSIP number

73017P607

Earnings date

2026-11-10

Earnings time

bmo

Employees

Employees change

Employees growth

1,033.33%

Enterprise value

$-2.7M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2020

Industry

Biotechnology

IPO date

2023-11-21

Is primary listing

Yes

Is SPAC

ISIN number

US73017P6079

Last 10-K release date

2026-03-30

Last earnings date

2026-08-14

Last refreshed

2026-10-28

Last stock split date

2026-08-21

Last stock split type

Reverse

Market cap

$2.1M

Market cap category

Nano-Cap

Next earnings date

2026-11-10

Options

Price

$2.56

Price currency

USD

Sector

Healthcare

SIC code

2834

Stock price date

2026-10-28

Symbol

ELAB

U.S. state

California

Website

https://pmgcholdings.com

Metric	Value
Earnings yield	-3,897.93%
FCF / EV yield	340.76%
FCF yield	-430.18%
P/B ratio	0.09x
P/S ratio	0.81x
Price / tangible book value	0.27x
Sector forward P/E	23.53x
Sector P/E	51.01x

Metric

Value

Earnings yield

-3,897.93%

FCF / EV yield

340.76%

FCF yield

-430.18%

P/B ratio

0.09x

P/S ratio

0.81x

Price / tangible book value

0.27x

Sector forward P/E

23.53x

Sector P/E

51.01x

Metric	Value
Gross margin	-20.51%
Operating margin	-469.96%
Pretax margin	-524.89%
Profit per employee	$-396,637
Revenue per employee	$75,844
ROA	-32.97%
ROA (5Y)	-63.39%
ROCE	-57.07%
ROE	-105.22%
ROE (5Y)	-169.18%
ROIC	-37.85%
SBC / revenue	8.01%
Tax / revenue	1.2%

Metric

Value

Gross margin

-20.51%

Operating margin

-469.96%

Pretax margin

-524.89%

Profit per employee

$-396,637

Revenue per employee

$75,844

ROA

-32.97%

ROA (5Y)

-63.39%

ROCE

-57.07%

ROE

-105.22%

ROE (5Y)

-169.18%

ROIC

-37.85%

SBC / revenue

8.01%

Tax / revenue

1.2%

Metric	Value
EPS growth quarters	2
EPS growth years	2
Net income growth years	0
Revenue growth (QoQ)	91.59%
Revenue growth 3Y	35.77%
Revenue growth years	0

Metric

Value

EPS growth quarters

EPS growth years

Net income growth years

Revenue growth (QoQ)

91.59%

Revenue growth 3Y

35.77%

Revenue growth years

Metric	Value
Capital expenditures	$-777,773
Depreciation and amortization	$574,348
EBIT	$-12.1M
EBITDA	$-11.5M
EPS	$-99.79
FCF per share	$-11.10
Financing cash flow	$29.6M
Free cash flow	$-9M
Free cash flow minus SBC	$-9.2M
Gross profit	$-528,822
Income taxes	$30,972
Investing cash flow	$-8.9M
Net borrowing	$51,883
Net cash flow	$12.5M
Net income	$-13.5M
Operating cash flow minus SBC	$-8.4M
Operating income	$-12.1M
Revenue	$2.6M
Stock-based compensation	$206,597

Metric

Value

Capital expenditures

$-777,773

Depreciation and amortization

$574,348

EBIT

$-12.1M

EBITDA

$-11.5M

EPS

$-99.79

FCF per share

$-11.10

Financing cash flow

$29.6M

Free cash flow

$-9M

Free cash flow minus SBC

$-9.2M

Gross profit

$-528,822

Income taxes

$30,972

Investing cash flow

$-8.9M

Net borrowing

$51,883

Net cash flow

$12.5M

Net income

$-13.5M

Operating cash flow minus SBC

$-8.4M

Operating income

$-12.1M

Revenue

$2.6M

Stock-based compensation

$206,597

Metric	Value
Altman Z-Score	-1.81
Book value per share	$27.20
Debt / equity	0.85
Goodwill	$3M
Interest coverage	-5.47
Long-term assets	$15.7M
Long-term liabilities	$4.5M
Net cash (debt)	$4.7M
Net cash / market cap	226.24%
Net cash growth	-25.52%
Net debt / equity	-0.28
Piotroski F-Score	1
Property, plant and equipment	$6.7M
Shareholders' equity	$16.7M
Tangible book value	$7.7M
Tangible book value per share	$12.52
Total assets	$36.6M
Total cash	$19M
Total debt	$14.2M
Total liabilities	$19.8M
WACC	11.07%

Metric

Value

Altman Z-Score

-1.81

Book value per share

$27.20

Debt / equity

0.85

Goodwill

$3M

Interest coverage

-5.47

Long-term assets

$15.7M

Long-term liabilities

$4.5M

Net cash (debt)

$4.7M

Net cash / market cap

226.24%

Net cash growth

-25.52%

Net debt / equity

-0.28

Piotroski F-Score

Property, plant and equipment

$6.7M

Shareholders' equity

$16.7M

Tangible book value

$7.7M

Tangible book value per share

$12.52

Total assets

$36.6M

Total cash

$19M

Total debt

$14.2M

Total liabilities

$19.8M

WACC

11.07%

Metric	Value
Asset turnover	0.11
Current assets	$20.8M
Current liabilities	$15.3M
Current ratio	1.36
Net working capital	$-3.7M
Quick ratio	1.28
Working capital	$5.5M
Working capital turnover	0.41

Metric

Value

Asset turnover

0.11

Current assets

$20.8M

Current liabilities

$15.3M

Current ratio

1.36

Net working capital

$-3.7M

Quick ratio

1.28

Working capital

$5.5M

Working capital turnover

0.41

Metric	Value
Dividend yield	0%

Metric

Value

Dividend yield

Metric	Value
150-day SMA	$15.02
1D price change	-0.77%
1M price change	-43.54%
1M total return	-43.54%
1W price change	-8.19%
1W total return	-8.19%
1Y price change	-99.82%
1Y return CAGR	-99.82%
1Y total return	-99.82%
20-day SMA	$2.94
200-day SMA	$37.79
3M price change	-71.95%
3M total return	-71.95%
50-day SMA	$4.18
50-day SMA vs 200-day SMA	50under200
52-week high	$1,537.32
52-week high date	2025-10-28
52-week low	$2.52
52-week low date	2026-10-27
6M price change	-89.84%
6M total return	-89.84%
All-time high	$4,991,414.80
All-time high date	2023-11-27
All-time low	$2.52
All-time low date	2026-10-27
Average true range (ATR)	$0.29
Average volume	20.7K
Beta (1Y)	7.67
Beta (2Y)	3.1
Beta (5Y)	-0.27
Change from 52-week high	-99.83%
Change from 52-week low	1.59%
Change from all-time high	-100%
Change from all-time low	2.38%
Change from open	-6.74%
Day's gap	6.4%
Dollar volume	$16,997
High price	$2.82
Low price	$2.57
Monthly RSI	0.47
Open price	$2.75
Position in 52-week range	0%
Premarket change	0.78%
Premarket close	$2.58
Premarket price	$2.60
Premarket volume	536
Previous close	$2.58
Price vs 150-day SMA	-82.82%
Price vs 20-day SMA	-12.27%
Price vs 200-day SMA	-93.17%
Price vs 50-day SMA	-38.25%
Relative volume	0.32
Return from IPO open	-100%
Return from IPO price	-35.5%
RSI	23.24
Sharpe ratio	-1.66
Sortino ratio	-2.89
Volume	6.6K
Weekly RSI	17.31
YTD price change	-99.27%
YTD total return	-99.27%

Metric

Value

150-day SMA

$15.02

1D price change

-0.77%

1M price change

-43.54%

1M total return

-43.54%

1W price change

-8.19%

1W total return

-8.19%

1Y price change

-99.82%

1Y return CAGR

-99.82%

1Y total return

-99.82%

20-day SMA

$2.94

200-day SMA

$37.79

3M price change

-71.95%

3M total return

-71.95%

50-day SMA

$4.18

50-day SMA vs 200-day SMA

50under200

52-week high

$1,537.32

52-week high date

2025-10-28

52-week low

$2.52

52-week low date

2026-10-27

6M price change

-89.84%

6M total return

-89.84%

All-time high

$4,991,414.80

All-time high date

2023-11-27

All-time low

$2.52

All-time low date

2026-10-27

Average true range (ATR)

$0.29

Average volume

20.7K

Beta (1Y)

7.67

Beta (2Y)

3.1

Beta (5Y)

-0.27

Change from 52-week high

-99.83%

Change from 52-week low

1.59%

Change from all-time high

-100%

Change from all-time low

2.38%

Change from open

-6.74%

Day's gap

6.4%

Dollar volume

$16,997

High price

$2.82

Low price

$2.57

Monthly RSI

0.47

Open price

$2.75

Position in 52-week range

Premarket change

0.78%

Premarket close

$2.58

Premarket price

$2.60

Premarket volume

536

Previous close

$2.58

Price vs 150-day SMA

-82.82%

Price vs 20-day SMA

-12.27%

Price vs 200-day SMA

-93.17%

Price vs 50-day SMA

-38.25%

Relative volume

0.32

Return from IPO open

-100%

Return from IPO price

-35.5%

RSI

23.24

Sharpe ratio

-1.66

Sortino ratio

-2.89

Volume

6.6K

Weekly RSI

17.31

YTD price change

-99.27%

YTD total return

-99.27%

Metric	Value
Float	764.2K
Float percentage	94.39%
Shares change (QoQ)	997.05%
Shares held by insiders	0%
Shares held by institutions	3.38%
Shares outstanding	809.6K
Short % of float	2.42%
Short % of shares	2.29%
Short ratio	0.5 days

Metric

Value

Float

764.2K

Float percentage

94.39%

Shares change (QoQ)

997.05%

Shares held by insiders

Shares held by institutions

3.38%

Shares outstanding

809.6K

Short % of float

2.42%

Short % of shares

2.29%

Short ratio

0.5 days

PMGC Holdings Inc. (ELAB)

Price

Financial snapshot

Fair-value bridge

Latest news · ELAB

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ELAB indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on ELAB

Frequently asked questions